Positive pre-clinical proof of concept studies in orexin-1 antagonist project

Chronos has demonstrated positive pre-clinical proof of concept (POC) results for the lead compound in its orexin-1 antagonist programme in an in vivo model of binge eating disorder (BED). Read the press release.